Outlook Therapeutics Inc (OTLK) Stock Price & News

Symbols Symbols	Price	Change	% Change	Trend	Prev Close	Open	High	Low	Volume	Mkt Cap
SIXB Materials SIXB Materials	SIXB -2,31%	1.041,53	-24,68	-2,31%	—	1.066,21	1.064,94	1.064,94	1.038,77	—	—
SIXC Communications SIXC Communications	SIXC -0,97%	605,26	-5,90	-0,97%	—	611,16	611,16	612,25	604,78	—	—
SIXE Energy SIXE Energy	SIXE +1,01%	1.282,74	+12,81	+1,01%	—	1.269,93	1.273,16	1.287,58	1.262,69	—	—
SIXI Industrials SIXI Industrials	SIXI -1,17%	1.700,27	-20,14	-1,17%	—	1.720,41	1.717,39	1.717,39	1.694,47	—	—
SIXM Financials SIXM Financials	SIXM -1,23%	629,31	-7,82	-1,23%	—	637,13	637,40	637,74	628,83	—	—
SIXR Staples SIXR Staples	SIXR +0,18%	867,83	+1,58	+0,18%	—	866,25	865,77	874,12	858,72	—	—
SIXRE Real estate SIXRE Real estate	SIXRE +0,43%	215,57	+0,93	+0,43%	—	214,64	214,64	216,08	213,49	—	—
SIXT Technology SIXT Technology	SIXT -0,66%	3.487,87	-23,26	-0,66%	—	3.511,13	3.481,07	3.527,59	3.440,20	—	—
SIXU Utilities SIXU Utilities	SIXU +0,99%	895,72	+8,80	+0,99%	—	886,92	885,23	896,83	881,74	—	—
SIXV Health care SIXV Health care	SIXV +1,09%	1.486,47	+15,98	+1,09%	—	1.470,49	1.470,68	1.494,42	1.462,16	—	—
SIXY Discretionary SIXY Discretionary	SIXY -1,12%	2.323,57	-26,20	-1,12%	—	2.349,77	2.332,17	2.332,17	2.307,43	—	—

OTLK:NASDAQ

Outlook Therapeutics Inc

US$0,23

-0,35%

(-0,00080) 1D

US$0,22

-2,58% (-0,0059)

After hours

Closed: 19 ພ.ພ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-4 · USD

All symbols

YTD

MAX

	Symbol	Price	Change	% Change

Generating top insights for OTLK...

Open

US$0,23

High

US$0,23

Low

US$0,22

Mkt. cap

໒໗,໕໑ ລ້ານ

Avg. vol.

໔,໙໙ ລ້ານ

Volume

໐,໐໐

52-wk high

US$3,39

52-wk low

US$0,16

EPS

US$-2,71

Beta

໐,໓໒

Shares outstanding

໑໒໐,໘໖ ລ້ານ

No. of employees

໑໗

Related stocks

RVPH

Reviva Pharmaceuticals Holdings Inc

Regeneron Pharmaceuticals Inc

US$630,30

+0,10%

News stories

From sources across the web

Minichart

1 ມື້ກ່ອນ

Outlook Therapeutics Reports Q2 2026 Financial Results, Updates on FDA Review and European Expansion of LYTENAVA (bevacizumab gamma)

Investing.com

1 ມື້ກ່ອນ

BTIG downgrades Outlook Therapeutics stock rating to neutral

AD HOC NEWS

2 ມື້ກ່ອນ

Outlook Therapeutics stock (US69012T1051): FDA feedback and capital raise keep focus on wet AMD path

Stock Titan

4 ມື້ກ່ອນ

Outlook Therapeutics (OTLK) Q2 2026 results show $4.5M loss and LYTENAVA push

About Outlook Therapeutics Inc

CEO-

Employees17

Founded2010

Headquarters-

SectorBiotechnology

Websiteoutlooktherapeutics.com

All values in USD	ມິ.ຖ. 2025	ກ.ຍ. 2025	ທ.ວ. 2025	ມ.ນ. 2026
Revenue	1,51 ລ້ານ	-91,79 ພັນ	-1,21 ລ້ານ	127,44 ພັນ
Cost of goods sold	7,57 ລ້ານ	6,90 ລ້ານ	3,66 ລ້ານ	149,33 ພັນ
Cost of revenue	7,57 ລ້ານ	6,90 ລ້ານ	3,66 ລ້ານ	149,33 ພັນ
Research and development expenses	-	-	-	4,50 ລ້ານ
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	9,68 ລ້ານ	10,33 ລ້ານ	8,61 ລ້ານ	9,50 ລ້ານ
Operating expense	9,68 ລ້ານ	10,33 ລ້ານ	8,61 ລ້ານ	14,01 ລ້ານ
Total operating expenses	17,25 ລ້ານ	17,22 ລ້ານ	12,28 ລ້ານ	14,15 ລ້ານ
Operating income	-15,75 ລ້ານ	-17,31 ລ້ານ	-13,48 ລ້ານ	-14,03 ລ້ານ
Other non operating income	-2,00 ລ້ານ	3,02 ລ້ານ	-2,79 ລ້ານ	6,84 ລ້ານ
EBT including unusual items	-20,15 ລ້ານ	-14,85 ລ້ານ	-23,06 ລ້ານ	-4,45 ລ້ານ
EBT excluding unusual items	-17,83 ລ້ານ	-14,51 ລ້ານ	-16,31 ລ້ານ	-7,23 ລ້ານ
Income tax expense	-	-1,55 ລ້ານ	-	-
Effective tax rate	-	10,47%	-	-
Other operating expenses	-	-	-	-
Net income	-20,15 ລ້ານ	-13,29 ລ້ານ	-23,06 ລ້ານ	-4,45 ລ້ານ
Net profit margin	-1.338,75%	14.482,19%	1.909,05%	-3.494,28%
Earnings per share	-0,44	-0,29	-0,22	-0,17
Interest and investment income	-	89,74 ພັນ	-	-
Interest expense	-49,35 ພັນ	-264,16 ພັນ	-	-
Net interest expenses	-49,35 ພັນ	-174,42 ພັນ	-	-
Depreciation and amortization charges	-	-	-	-
EBITDA	-15,72 ລ້ານ	-17,28 ລ້ານ	-13,45 ລ້ານ	-14,00 ລ້ານ
Gain or loss from assets sale	-	-	-	-

AI content may include mistakes. Learn more

HelpSend feedbackPrivacy Terms Disclaimer

Finance

Research